
Reset all filters
01 1Torys LLP
Reset all filters
01 12335300
Reset all filters
01 1eribulin mesylate
Reset all filters
01 1Solution for injection
Reset all filters
01 12019-06-16
Patent Expiration Date : 2019-06-16
Date Granted : 2008-10-07
Brand Name : HALAVEN
Patent Number : 2335300
Filing Date : 1999-06-16
Strength per Unit : 0.5 mg / mL
Dosage Form : Solution for injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-06-16
Date Granted : 2008-10-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF